Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glycopyrronium bromide 600micrograms/3ml inj ampoules
1501030G0AAABAB
|
Glycopyrronium brom (Pre-med) | Glycopyrronium bromide | Anaesthesia | 6,055 |
|
Nitrofurantoin 25mg/5ml oral suspension sugar free
0501130R0AAACAC
|
Nitrofurantoin | Nitrofurantoin | Infections | 6,054 |
|
Pilocarpine 5mg tablets
1203050P0AAABAB
|
Pilocarpine hydrochloride (Systemic) | Pilocarpine hydrochloride | Ear, Nose and Oropharynx | 6,053 |
|
Tetracycline 250mg tablets
0501030V0AAAFAF
|
Tetracycline (Systemic) | Tetracycline | Infections | 6,052 |
|
Mesalazine 400mg gastro-resistant tablets
0105010B0AAAAAA
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 6,044 |
|
Independence Fusion 1ml applicator
23801068002
|
Independence Fusion 1ml applicator | Skin Fillers And Protectives | Stoma Appliances | 6,018 |
|
Tylex 30mg/500mg capsules
0407010F0BEAAAD
|
Tylex | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 6,007 |
|
Zonegran 100mg capsules
0408010ADBBADAA
|
Zonegran | Zonisamide | Central Nervous System | 5,998 |
|
Conveen Optima latex free self-sealing Urisheath standard length 30mm
22301003068
|
Conveen Optima latex free self-sealing Urisheath standard length 30mm | Incontinence Sheaths | Incontinence Appliances | 5,993 |
|
Allevyn Adhesive dressing 7.5cm x 7.5cm square
20030600020
|
Allevyn Adhesive dressing 7.5cm x 7.5cm square | Wound Management & Other Dressings | Dressings | 5,986 |
|
Libra sterile catheter valve
22052080501
|
Libra sterile catheter valve | Catheter Valves | Incontinence Appliances | 5,984 |
|
Eslicarbazepine 800mg tablets
0408010AIAAAAAA
|
Eslicarbazepine acetate | Eslicarbazepine acetate | Central Nervous System | 5,983 |
|
Lorazepam 2.5mg tablets
0401020P0AAACAC
|
Lorazepam | Lorazepam | Central Nervous System | 5,981 |
|
Dioralyte oral powder sachets citrus
0902012H0BBAFAE
|
Dioralyte | Oral rehydration salts | Nutrition and Blood | 5,978 |
|
Glycerol 1g suppositories
0106020L0AAAAAA
|
Glycerol (Systemic) | Glycerol | Gastro-Intestinal System | 5,973 |
|
Ensure Plus Advance liquid (5 flavours)
0913011K0BCAAAE
|
Ensure RtS 1.5 - 1.6 kcal/ml milkshake higher protein | RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | Nutrition and Blood | 5,970 |
|
Minims artificial tears 0.44% eye drops 0.5ml unit dose
1108010H0BBAAAA
|
Minims artificial tears | Hyetellose | Eye | 5,969 |
|
Dansac TRE Seals 30mm
23850708519
|
Dansac TRE Seals 30mm | Skin Protectors | Stoma Appliances | 5,968 |
|
Valsartan 320mg tablets
0205052V0AAAFAF
|
Valsartan | Valsartan | Cardiovascular System | 5,963 |
|
Octasa 1600mg MR gastro-resistant tablets
0105010B0BIACBD
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 5,962 |
|
Compression hosiery class I below knee stocking circular knit made to measure
21070410111
|
Compression hosiery class I below knee stocking circular knit made to measure | Elastic Hosiery | Appliances | 5,954 |
|
Guide testing strips
0601060D0EQAAA0
|
Guide (Reagent) | Glucose blood testing reagents | Endocrine System | 5,947 |
|
Ondansetron 4mg/5ml oral solution sugar free
0406000S0AAAGAG
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 5,947 |
|
Hydrocortisone 0.5% ointment
1304000V0AABBBB
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 5,945 |
|
Pyridoxine 10mg tablets
0906024N0AAAGAG
|
Pyridoxine hydrochloride | Pyridoxine hydrochloride | Nutrition and Blood | 5,944 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.